Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Compugen Ltd (NASDAQ:CGEN)

5.10
Delayed Data
As of 3:59pm ET
 +0.10 / +2.00%
Today’s Change
4.64
Today|||52-Week Range
10.02
-38.78%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$252.3M

Company Description

Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Tel Aviv, Israel.

Contact Information

Compugen Ltd.
72 Pinchas Rosen Street
Tel Aviv Tel Aviv 69512
P:(723) 765-8585
Investor Relations:

Employees

Shareholders

Mutual fund holders6.19%
Other institutional4.89%
Individual stakeholders--

Top Executives

Anat Cohen-DayagPresident & Chief Executive Officer
Ari KrashinChief Financial Officer
Eyal NeriaVice President-Research & Development
Zurit LevineVice President-Research & Discovery
Tsipi Keren-LehrerVice President-Business Development